NCCN Prostate Cancer Guidelines Review

Medicare Part D 2025 Reduces Out-of-Pocket Costs for Oral Prostate Cancer Treatments - David Morris

September 25, 2024

Details

2024 NCCN Guidelines: Simplifying the Management of Very Low-Risk Prostate Cancer - Rashid Sayyid & Zachary Klaassen

June 19, 2024

Details

MMAI Model Risk Stratification for NCCN Guidelines for Low, Intermediate, and High-Risk Prostate Cancer - Neal Shore, Daniel Spratt, & Alicia Morgans

June 4, 2024

Details

NCCN Clinical Practice Guidelines in Prostate Cancer: Radical Prostatectomy – Zachary Klaassen

March 16, 2023

Details

NCCN Clinical Practice Guidelines in Prostate Cancer 177-Lutetium PSMA (LuPSMA) Radioligand Therapy - Zachary Klaassen

March 16, 2023

Details

NCCN Clinical Practice Guidelines in Prostate Cancer Radiation Therapy: Brachytherapy, Proton Therapy, and Radiation for Distant Metastasis - Zachary Klaassen

March 16, 2023

Details

NCCN Clinical Practice Guidelines in Prostate Cancer Radiation Therapy: External Beam Radiation Therapy - Zachary Klaassen

March 16, 2023

Details

NCCN Guidelines 2022 - Prostate Cancer on Comparison of Treatment Options for Localized Disease + Local Therapies + Disease Monitoring - Zachary Klaassen and Chris Wallis

January 17, 2022

Details

NCCN Guideline Review on Prostate Cancer - Epidemiology, Initial Diagnosis, and Life Expectancy of Men With Prostate Cancer: Journal Club – Christopher Wallis & Zachary Klaassen

November 18, 2021

Details

NCCN Guidelines on Prostate Cancer Reviewing Advanced Prostate Cancer Neuroendocrine Disease, Bone and Visceral Metastases, and Treatment Sequencing – Christopher Wallis & Zachary Klaassen

November 12, 2021

Details

NCCN Prostate Cancer Clinical Practice Guidelines on Risk Stratification for Clinically Localized Prostate Cancer – Christopher Wallis & Zachary Klaassen

November 10, 2021

Details

Observation and Active Surveillance in the NCCN Prostate Cancer Guidelines- Christopher Wallis and Zachary Klaassen

November 9, 2021

Details

NCCN Guidelines - Staging Evaluation and Imaging Approaches in Prostate Cancer – Christopher Wallis and Zachary Klaassen

November 7, 2021

Details

NCCN Guidelines on Prostate Cancer Genetics - Christopher Wallis & Zachary Klaassen

October 31, 2021

Details

NCCN Guidelines on Prostate Cancer - A Focus on Chemotherapy, Immunotherapy, and Targeted Therapy in Advanced Prostate Cancer - Christopher Wallis and Zachary Klaassen

October 13, 2021

Details

NCCN Guidelines on Prostate Cancer: A Focus on Chemotherapy, Immunotherapy, and Targeted Therapy in Advanced Prostate Cancer - Chemotherapeutic Approaches - Christopher Wallis and Zachary Klaassen

October 13, 2021

Details

Intermittent vs Continuous ADT for Patients A Review of the NCCN Guidelines – Christopher Wallis and Zachary Klaassen

September 13, 2021

Details

ADT for Castration-Naive Disease A Review of the NCCN Prostate Cancer Guidelines – Christopher Wallis and Zachary Klaassen

September 13, 2021

Details

NCCN Guidelines on Prostate Cancer: A Focus on Castration-Resistant Prostate Cancer - Christopher Wallis and Zachary Klaassen

August 31, 2021

Details

The NCCN Guidelines on Androgen Deprivation Therapy in Localized Disease, Regional Disease, and Palliative Treatment - Christopher Wallis and Zachary Klaassen

August 31, 2021

Details